Prescription drug · ANDA
Piperacillin and Tazobactam NDC 0781-3117
Piperacillin sodium 12 g/100mL; Tazobactam sodium 1.5 g/100mL · Injection, Powder, Lyophilized, For solution · Intravenous, Parenteral · Sandoz Inc
NDC codes
FDA NDC DirectoryProduct information
- Brand name (proprietary)
- Piperacillin and Tazobactam
- Generic name (nonproprietary)
- piperacillin and tazobactam
- Active ingredients
- Piperacillin sodium — 12 g/100mLTazobactam sodium — 1.5 g/100mL
- Dosage form
- Injection, Powder, Lyophilized, For solution
- Route
- Intravenous, Parenteral
- Labeler
- Sandoz Inc
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 203557
- Marketing start
- Listing expires
- Other FDA classes
- Penicillins (Chemical structure)beta Lactamase Inhibitors (Mechanism)
- Identifiers
- Product ID 0781-3117_27be0ff3-ee57-4d56-a73b-ca773d763a1eSPL ID 27be0ff3-ee57-4d56-a73b-ca773d763a1eSPL set ID b1cb1314-d3e0-4b44-a1df-de14c32e8cc6RxCUI 312447UNII UXA545ABTT, M98T69Q7HP
- Pharmacologic class
- Penicillin-class Antibacterial; beta Lactamase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Piperacillin and tazobactam for injection is a combination of piperacillin, a penicillin-class antibacterial and tazobactam, a beta-lactamase inhibitor, indicated for the treatment of: • Intra-abdominal infections in adult and pediatric patients 2 months of age and older ( 1.1 ) • Nosocomial pneumonia in adult and pediatric patients 2 months of age and older ( 1.2 ) • Skin and skin structure infections in adults ( 1.3 ) • Female pelvic infections in adults ( 1.4 ) • Community-acquired pneumonia in adults ( 1.5 ) To reduce the development of drug-resistant bacteria and maintain the effectiveness of piperacillin and tazobactam for injection and other antibacterial drugs, piperacillin and tazob…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 203557
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Piperacillin and Tazobactam | Piperacillin sodium 36 g/250mL; Tazobactam sodium 4.5 g/250mL | Injection, Powder, Lyophilized, For solutionIntravenous, Parenteral | Sandoz Inc | 0781-3180 |
| Piperacillin and Tazobactam | Piperacillin sodium 12 g/60mL; Tazobactam sodium 1.5 g/60mL | Injection, Powder, Lyophilized, For solutionIntravenous, Parenteral | Hospira, Inc | 0409-2999 |